Furukawa TA - Search Results

1

Some concerns about exclusion of participants.

Kawashima H, Toyomoto R, Furukawa TA. Kawashima H, et al. Among authors: furukawa ta. Brain Stimul. 2023 Jul-Aug;16(4):1205. doi: 10.1016/j.brs.2023.06.015. Epub 2023 Jul 26. Brain Stimul. 2023. PMID: 37620098 Free article. No abstract available.

2

The gender difference in expressed concerns about hazardous drinking in primary care settings.

Nishimura H, So R, Kariyama K, Oyamada S, Matsushita S, Furukawa TA, Nouso K. Nishimura H, et al. Among authors: furukawa ta. Gen Hosp Psychiatry. 2024 Sep-Oct;90:198-199. doi: 10.1016/j.genhosppsych.2024.06.008. Epub 2024 Jun 14. Gen Hosp Psychiatry. 2024. PMID: 38906775 No abstract available.

3

Complexities of treatment-resistant depression: cautionary notes and promising avenues.

Furukawa TA. Furukawa TA. World Psychiatry. 2023 Oct;22(3):419-420. doi: 10.1002/wps.21139. World Psychiatry. 2023. PMID: 37713561 Free PMC article. No abstract available.

4

How should narcissism be treated best?

Klein JP, Schaich A, Furukawa TA. Klein JP, et al. Among authors: furukawa ta. Lancet Psychiatry. 2023 Dec;10(12):914-916. doi: 10.1016/S2215-0366(23)00307-3. Epub 2023 Oct 13. Lancet Psychiatry. 2023. PMID: 37844593 No abstract available.

5

"Meta-epidemiological study" is a study in which the unit of analysis is a study, not a patient; response to Puljak et al.

Kataoka Y, Banno M, Tsujimoto Y, Furukawa TA. Kataoka Y, et al. Among authors: furukawa ta. J Clin Epidemiol. 2023 Feb;154:219-220. doi: 10.1016/j.jclinepi.2022.12.002. Epub 2022 Dec 9. J Clin Epidemiol. 2023. PMID: 36503003 No abstract available.

6

Evaluating the substance use disorder treatment gap in the United States, 2016-2019: A population health observational study.

Sahker E, Pro G, Poudyal H, Furukawa TA. Sahker E, et al. Among authors: furukawa ta. Am J Addict. 2024 Jan;33(1):36-47. doi: 10.1111/ajad.13465. Epub 2023 Aug 15. Am J Addict. 2024. PMID: 37583093

7

Guided versus unguided chatbot-delivered cognitive behavioral intervention for individuals with moderate-risk and problem gambling: A randomized controlled trial (GAMBOT2 study).

So R, Emura N, Okazaki K, Takeda S, Sunami T, Kitagawa K, Takebayashi Y, Furukawa TA. So R, et al. Among authors: furukawa ta. Addict Behav. 2024 Feb;149:107889. doi: 10.1016/j.addbeh.2023.107889. Epub 2023 Oct 13. Addict Behav. 2024. PMID: 37857043 Clinical Trial.

8

Beyond the Pass Mark: Accuracy of ChatGPT and Bing in the National Medical Licensure Examination in Japan.

Kataoka Y, Yamamoto-Kataoka S, So R, Furukawa TA. Kataoka Y, et al. Among authors: furukawa ta. JMA J. 2023 Oct 16;6(4):536-538. doi: 10.31662/jmaj.2023-0043. Epub 2023 Sep 20. JMA J. 2023. PMID: 37941716 Free PMC article. No abstract available.

9

Global Trends in Highly Cited Studies in COVID-19 Research.

Funada S, Yoshioka T, Luo Y, Iwama T, Mori C, Yamada N, Yoshida H, Katanoda K, Furukawa TA. Funada S, et al. Among authors: furukawa ta. JAMA Netw Open. 2023 Sep 5;6(9):e2332802. doi: 10.1001/jamanetworkopen.2023.32802. JAMA Netw Open. 2023. PMID: 37682572 Free PMC article.

10

An extension minimal important difference credibility item addressing construct proximity is a reliable alternative to the correlation item.

Wang Y, Devji T, Carrasco-Labra A, Qasim A, Hao Q, Kum E, Devasenapathy N, King MT, Terluin B, Terwee CB, Walsh M, Furukawa TA, Tsujimoto Y, Guyatt GH. Wang Y, et al. Among authors: furukawa ta. J Clin Epidemiol. 2023 May;157:46-52. doi: 10.1016/j.jclinepi.2023.03.001. Epub 2023 Mar 5. J Clin Epidemiol. 2023. PMID: 36878330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

718 results

Search Page

Filters